| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +25.00% | +5.91% | +0.02% | +5.89% | +2.48% | — |
| 14d | 8 | +50.00% | +3.38% | +0.70% | +2.67% | +7.03% | — |
| 30d | 8 | +25.00% | +0.25% | +0.37% | -0.12% | +2.17% | — |
| 60d | 8 | +50.00% | +7.80% | +5.93% | +1.86% | -0.05% | — |
| 90d | 8 | +50.00% | +16.95% | +9.24% | +13.50% | +5.93% | — |
| 180d | 8(1 pending) | +42.86% | +13.04% | +16.29% | -3.25% | -5.57% | — |
| 1y | 8(2 pending) | +50.00% | +18.36% | +31.18% | -38.50% | -25.36% | — |
| 2y | 8(4 pending) | +0.00% | -77.48% | +52.00% | -129.48% | -139.96% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KARD KARDIGAN, INC. | PURCHASE | 1,250,000 | $16.00 | $20.00M | 15,042,035 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | SALE | 2,306,401 | — | — | 0 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | PURCHASE | 13,792,035 | — | — | 13,792,035 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | SALE | 5,148,587 | — | — | 0 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| KARD KARDIGAN, INC. | SALE | 1,204,000 | — | — | 0 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 4,310 | — | — | 4,310 | Jun 4, 2026 | Jun 8, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 6,839 | — | — | 117,710 | Jun 4, 2026 | Jun 8, 2026 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | May 27, 2026 | May 29, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASE | 28,000 | $4.75 | $133.0K | 56,871 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE | 18,000 | — | — | 0 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASE | 18,000 | $8.36 | $150.5K | 110,871 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE | 28,000 | — | — | 0 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE | 36,000 | — | — | 0 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASE | 7,800 | $26.78 | $208.9K | 28,871 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASE | 36,000 | $9.11 | $328.0K | 92,871 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE | 7,800 | — | — | 0 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASE | 488,090 | $25.61 | $12.50M | 1,426,528 | Mar 6, 2026 | Mar 9, 2026 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,915,700 | $2.61 | $5.00M | 6,046,907 | Oct 27, 2025 | Oct 29, 2025 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 3,030,300 | $3.30 | $10.00M | 6,230,300 | Aug 1, 2025 | Aug 1, 2025 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASEGRANT Stock grant | 16,000 | — | — | 16,000 | Jun 23, 2025 | Jun 23, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE10b5-1 10b5-1 plan | 1,000 | $29.24 | $29.2K | 25,471 | May 29, 2025 | May 30, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE10b5-1 10b5-1 plan | 4,400 | $29.83 | $131.3K | 21,071 | May 29, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 46,455 | — | — | 0 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,571 | — | — | 28,571 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 28,571 | — | — | 0 | May 28, 2025 | May 30, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,455 | — | — | 46,455 | May 28, 2025 | May 30, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 7,632 | — | — | 26,471 | May 22, 2025 | May 23, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 9,206 | — | — | 9,206 | May 22, 2025 | May 23, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 28,571 | — | — | 0 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 46,455 | — | — | 0 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,455 | — | — | 46,455 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,571 | — | — | 28,571 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 13,500 | — | — | 18,839 | Jun 27, 2024 | Jul 1, 2024 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 18,000 | — | — | 18,000 | Jun 27, 2024 | Jul 1, 2024 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,100 | — | — | 47,717 | Jun 13, 2024 | Jun 14, 2024 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,571 | — | — | 28,571 | Jun 13, 2024 | Jun 14, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE | 11,924,138 | — | — | 0 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | PURCHASE | 3,728,738 | — | — | 3,728,738 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| RAPP RAPPORT THERAPEUTICS, INC. | SALE | 20,000,000 | — | — | 0 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 227,920 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 1,048,433 | — | — | 1,048,433 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 586,080 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 66,667 | $16.00 | $1.07M | 683,759 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 787,545 | — | — | 828,570 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 366,301 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 589,743 | — | — | 617,092 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 164,835 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 201,465 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 424,908 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASE | 133,333 | $16.00 | $2.13M | 1,181,766 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | SALE | 454,212 | — | — | 0 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| BOLD BOUNDLESS BIO, INC. | PURCHASEGRANT Stock grant | 26,438 | — | — | 26,438 | Mar 27, 2024 | Mar 29, 2024 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 3,200,000 | $6.25 | $20.00M | 3,200,000 | Feb 15, 2024 | Feb 20, 2024 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 727,272 | $5.50 | $4.00M | 12,446,022 | Feb 8, 2024 | Feb 12, 2024 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 363,637 | $5.50 | $2.00M | 10,667,387 | Feb 8, 2024 | Feb 12, 2024 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | SALE | 291,906 | — | — | 2,345,711 | Dec 21, 2023 | Dec 26, 2023 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASE | 5,339 | — | — | 5,339 | Dec 21, 2023 | Dec 26, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,176,593 | — | — | 4,131,207 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 703,061 | — | — | 1,387,228 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 13,997 | — | — | 27,617 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 3,357 | $11.98 | $40.2K | 4,131,207 | Nov 14, 2023 | Nov 15, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 31,653 | $11.75 | $371.9K | 4,127,850 | Nov 13, 2023 | Nov 15, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 11,844 | $11.37 | $134.7K | 4,090,766 | Nov 10, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 5,431 | $11.75 | $63.8K | 4,096,197 | Nov 10, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 31,079 | $10.53 | $327.3K | 4,078,922 | Nov 9, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 23,124 | $11.79 | $272.6K | 4,047,843 | Nov 8, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 69,127 | $10.78 | $745.2K | 4,024,719 | Nov 8, 2023 | Nov 13, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 30,192 | $11.50 | $347.2K | 3,955,592 | Nov 7, 2023 | Nov 7, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 43,082 | $11.55 | $497.6K | 3,925,400 | Nov 6, 2023 | Nov 7, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 22,420 | $11.38 | $255.1K | 3,882,318 | Nov 3, 2023 | Nov 7, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 34,560 | $13.98 | $483.1K | 3,859,898 | Sep 29, 2023 | Sep 29, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 16,841 | $13.06 | $219.9K | 3,800,228 | Sep 28, 2023 | Sep 29, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 25,110 | $13.69 | $343.8K | 3,825,338 | Sep 28, 2023 | Sep 29, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 24,504 | $12.31 | $301.6K | 3,783,387 | Sep 27, 2023 | Sep 27, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 34,000 | $11.73 | $398.8K | 3,758,883 | Sep 26, 2023 | Sep 27, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 29,967 | $11.65 | $349.1K | 3,724,883 | Sep 25, 2023 | Sep 25, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 30,773 | $10.80 | $332.3K | 3,694,916 | Sep 25, 2023 | Sep 25, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 40,000 | $11.14 | $445.6K | 3,664,143 | Sep 22, 2023 | Sep 25, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 6,576,400 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 2,124,143 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 6,895,021 | — | — | 12,205,379 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 6,576,400 | — | — | 11,886,758 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,500,000 | $17.00 | $25.50M | 3,624,143 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 684,167 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 1,144,973 | — | — | 1,144,973 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 684,167 | — | — | 684,167 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 2,124,143 | — | — | 2,124,143 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 6,895,021 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 1,144,973 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASE | 13,620 | — | — | 13,620 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | SALE | 13,620 | — | — | 0 | Sep 19, 2023 | Sep 19, 2023 ↗ | View → |
| NMRA NEUMORA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,455 | — | — | 46,455 | Sep 14, 2023 | Sep 18, 2023 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 36,000 | — | — | 36,000 | Jun 21, 2023 | Jun 22, 2023 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 35,000 | — | — | 35,000 | Jun 8, 2023 | Jun 9, 2023 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 16,532 | — | — | 16,532 | Jun 6, 2023 | Jun 8, 2023 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 400,000 | $17.00 | $6.80M | 6,128,297 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | PURCHASE | 5,728,297 | — | — | 5,728,297 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 16,666,667 | — | — | 0 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 1,141,474 | — | — | 0 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| PRME PRIME MEDICINE, INC. | SALE | 16,666,664 | — | — | 0 | Oct 24, 2022 | Oct 26, 2022 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 10,391 | — | — | 10,391 | Sep 1, 2022 | Sep 2, 2022 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jun 9, 2022 | Jul 15, 2022 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 28,000 | — | — | 28,000 | May 26, 2022 | May 27, 2022 ↗ | View → |
| ERAS ERASCA, INC. | PURCHASE | 5,527,777 | — | — | 5,527,777 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE | 3,400,000 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE | 2,100,000 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| ERAS ERASCA, INC. | SALE | 1,133,333 | — | — | 0 | Jul 20, 2021 | Jul 20, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 2,921,520 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 2,921,519 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,011 | — | — | 12,067 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,121,519 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,011 | — | — | 10,056 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,121,520 | Jun 29, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,321,519 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,011 | — | — | 8,045 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,321,520 | Jun 25, 2021 | Jun 29, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 6,877 | — | — | 6,877 | Jun 10, 2021 | Jun 14, 2021 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 23,500 | — | — | 23,500 | Jun 9, 2021 | Jun 10, 2021 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 7,800 | — | — | 7,800 | May 27, 2021 | Jun 1, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,521,520 | Mar 31, 2021 | Apr 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,521,519 | Mar 31, 2021 | Apr 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,011 | — | — | 6,034 | Mar 31, 2021 | Apr 2, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,721,519 | Mar 22, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,011 | — | — | 4,023 | Mar 22, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,721,520 | Mar 22, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,921,520 | Mar 18, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 200,000 | — | — | 3,921,519 | Mar 18, 2021 | Mar 22, 2021 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 2,012 | — | — | 2,012 | Mar 18, 2021 | Mar 22, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 781,250 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 5,687,500 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 10,156,250 | — | — | 10,301,250 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 3,687,500 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 2,343,750 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 10,156,250 | — | — | 10,303,750 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | SALE | 9,375,000 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SANA SANA BIOTECHNOLOGY, INC. | PURCHASE | 11,718,750 | — | — | 11,718,750 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| GOSS GOSSAMER BIO, INC. | PURCHASEGRANT Stock grant | 23,500 | — | — | 23,500 | Jun 17, 2020 | Jun 18, 2020 ↗ | View → |
| SRRK SCHOLAR ROCK HOLDING CORP | PURCHASEGRANT Stock grant | 13,000 | — | — | 13,000 | Jun 16, 2020 | Jun 18, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 28,888 | — | — | 28,888 | May 21, 2020 | May 22, 2020 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 25,404 | — | — | 25,404 | May 21, 2020 | Oct 13, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,121,520 | — | — | 4,121,520 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 2,750,336 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | PURCHASE | 4,121,519 | — | — | 4,121,519 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 33,184 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 2,750,335 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| BEAM BEAM THERAPEUTICS INC. | SALE | 1,338,000 | — | — | 0 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |